Form D · Other Health Care
TransCardiac Therapeutics, Inc.
Atlanta, GA · CIK 0001464911
Offering snapshot reported Jul 30, 2009 · SEC filing
- Reported sold
- $200K Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 24, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2009 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-133215
Source: Form D, filed Jul 30, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wayne Alexander | Director |
| Michael Fowler | Executive |
| Larry Hall | Director |
| Omar Lattouf | Director, Executive |
| Lina Lattouf | Director, Executive |
| Russ Medford | Director |
| David Smith | Executive |
| Ahmed Zaki | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3355 Lenox Road Ne Suite 415
Atlanta, GA, 30326
Atlanta, GA, 30326